2020 ASCO Virtual Direct™ Highlights
Hematologic Oncology
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Updates on IDH1-Mutated AML: Do Ivosidenib & Venetoclax Work Better Alone or in Combination With Azacitidine?
FEATURING
Terrence Bradley
- 143 views
- September 29, 2020
- 1
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on R/R AML: Is AMG 330 Safe and Tolerable? How Should We Manage CRS?
FEATURING
Terrence Bradley
- 45 views
- September 29, 2020
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Updates on MDS/AML: How Does Magrolimab Work With AZA? What Is the Effect on the TP53 Mutation?
FEATURING
Terrence Bradley
- 91 views
- September 29, 2020
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on R/R Hodgkin Lymphoma: Can We Consider Pembrolizumab a New SoC?
FEATURING
William Hammond
- 146 views
- August 25, 2020
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on Lymphomas: Is Axi-Cel Effective in R/R Indolent Lymphoma?
FEATURING
William Hammond
- 136 views
- August 25, 2020
- 1
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on CLL: Does Venetoclax + da-EPOCH-R Show Promise for Richter’s Syndrome?
FEATURING
William Hammond
- 116 views
- August 25, 2020